Purchase Order 75N93021P01384
Award Date 9/20/21
Potential Completion Date 6/11/23
Potential Value $68K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $375,000.00 sole source contract to DNA Twopointo Inc., doing business as ATUM Biosciences, for a license to use ATUM's proprietary cell line technology for the production of an engineered antibody (PGDM1400.LS) to support ongoing AIDS clinical trials. The contract has a one-year base period starting May 14, 2023, with four one-year option periods extending to May 13, 2028. There is no set-aside...
- This firm fixed-price purchase order for $9,150.00 was awarded to DNA Twopointo Inc. (doing business as ATUM Biosciences) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to provide other functions related to adenovirus vector construction. The award does not have a set-aside designation. DNA Twopointo Inc. is a for-profit manufacturer that has previously received federal contracts and grants from various agencies, including NIAID, the Naval Sea Systems...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to DNA Twopointo Inc. (doing business as ATUM Biosciences) for gene card and gene synthesis services. The contract has a ceiling value of $9,500.00 and was awarded on November 15, 2011 with a final completion date of September 30, 2012. The contract is not set aside for any specific business category. DNA Twopointo Inc....
- This federal contract award to DNA Twopointo Inc. (doing business as ATUM Biosciences) was made by the Northeast Area of the U.S. government agency on August 3, 2015 for DNA-related services. The $10,800 firm-fixed-price purchase order has a completion date of September 30, 2015 and was not set aside for any specific business type. DNA Twopointo Inc. has previously performed as both a prime and subcontractor on other federal awards with the National Institute of Allergy and Infectious...
- This is a $10,000 firm fixed-price purchase order awarded by the Forest Products Laboratory of the U.S. Forest Service to DNA Twopointo Inc., doing business as ATUM Biosciences, for the GENECARD project. The contract has no set-aside designation. ATUM Biosciences provides tools and solutions for the life sciences industry, including gene design and synthesis, protein and antibody services, and GMP cell line development. The company has previously been awarded federal contracts for work...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Geneart AG, a subsidiary of Life Technologies Corporation, for the purchase of a plasmid derived from a microorganism with catalog number 81003. The $21,802.71 purchase order contract, which did not have a set-aside designation, was awarded on September 11, 2009 with a completion date of November 13, 2009. Life Technologies, as...
- This federal contract award, with the ID HHSN272201000923P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. Department of Health and Human Services. The contract, with a firm fixed price of $21,616.50, was awarded to Immune Technology Corp., a minority-owned, Asian-Pacific American-owned, for-profit manufacturer of goods. The contract is for the production of 200 mg plasmid DNA, designated as VRC 5566, for NIAID's Vaccine Research Center (VRC). The...
- This firm-fixed-price BPA call award to Life Technologies Corporation (Thermofisher Scientific) is for the provision of TOPO TA Cloning Dual Vector Kit reagents for the National Human Genome Research Institute, a civilian federal agency under the National Institutes of Health. The $20,338.00 contract has an ultimate completion date of April 30, 2012. Life Technologies, the prime contractor, has provided these genetic analysis products and associated services to support the Institute's biomedical...
- This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
- This federal contract award is for the purchase of 30 units of the AMBIS 1780815 RNA ULTRASENSE QRT-PCR MIX 100 RXNS, cat # 11732927, at a total ceiling value of $9,936.00. The contract was awarded to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that serves as a prime contractor across various federal agencies. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human...
DNA TWOPOINTO, INC. (ATUM) HAS "EVALUATION LICENSE AND MATERIALS: CELL LINE DEVELOPMENT EXPRESSION VECTOR OPTIMIZATION" NEEDED BY NIAID'S VACCINE RESEARCH CENTER. AMBIS #2075993
Posted 9/20/21
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Post-Award Notice-Justification for ATUM Evaluation License and Materials: Cell Line Development Expression Vector Optimization | 75N93021P01384 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Limited / Sole Source Justification 2/2 | 10/7/21, 4:48 PM | |
ATUM Evaluation License and Materials: Cell Line Development Expression Vector Optimization | NIAID_NOI21_2075993 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Pre-Solicitation 1/2 | 7/27/21, 5:22 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Supplemental Agreement for work within scope | $0 | 12/5/22 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 3/21/22 | |
| P00002 | Supplemental Agreement for work within scope | ($85) | 12/10/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/7/21 | |
| Not listed | Not listed | $68.2k | 9/20/21 |